Morphine promotes rapid, arrestin-dependent endocytosis of mu-opioid receptors in striatal neurons

Authors:
Haberstock-Debic H, Kim KA, Yu YJ and von Zastrow M
In:
Source: J Neurosci
Publication Date: (2005)
Issue: 25(34): 7847-7857
Research Area:
Neurobiology
Platform:
Nucleofector® I/II/2b
Experiment
In order to assess receptor internalisation, striatal neurons were nucleofected to express FLAG-MOR. Surface receptors were labelled with Alexa591-M1 antibody and then cells were incubated 30 minutes with or without agonist, fixed, and residual surface receptors labelled with Alexa488 donkey anti-mouse secondary antibody for study by quantitative fluorescence microscopy.
Abstract
Morphine activates mu-opioid receptors (MORs) without promoting their rapid endocytosis in a number of cell types. A previous study suggested that morphine can drive rapid redistribution of MORs in the nucleus accumbens, but it was not possible in this in vivo study to identify a specific membrane trafficking pathway affected by morphine, to exclude possible indirect actions of morphine via opiate-regulated neural circuitry, or to define the mechanism of this morphine-dependent regulation. In the present study, we addressed these questions using dissociated primary cultures of rat striatal neurons as a model system. Morphine promoted a rapid redistribution of both endogenous and recombinant MORs within 30 min after drug addition to the culture medium. This effect was mediated by rapid endocytosis and occurred in a cell-autonomous manner, as indicated by its detection in cells plated at low density and in cultures in which depolarization was blocked by tetrodotoxin. Morphine-induced endocytosis of MORs was quantitatively similar to that induced by the enkephalin analog D-Ala2-N-Me-Phe4-Glycol5-enkephalin, and endocytosis induced by both ligands was inhibited by a dominant-negative mutant version of arrestin-3 (beta-arrestin-2). These results extend previous in vivo results and indicate that morphine is indeed capable of driving rapid endocytosis of mu-opioid receptors in an important subset of opiate-responsive CNS neurons. They also suggest a cellular mechanism by which beta-arrestins may modulate the physiological effects of morphine in vivo.